Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INNOVATE-PCI
2008-001352-51Phase 2Completed
- Sponsor
- Portola Pharmaceuticals
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronary arteriosclerosis comparing PRT060128 with Plavix (2 arms). Primary endpoint: Efficacy endpoints. Started Oct 2008; status: completed.
02
Drugs
elinogrelclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-001352-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001352-51.